Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1

Masatoshi Yamato, Yasuo Takeuchi, Kuniko Hashigaki, Yuji Ikeda, Chang Ming-rong, Kyoko Takeuchi, Mayumi Matsushima, Takashi Tsuruo, Tazuko Tashiro, Shigeru Tsukagoshi, Yoshinori Yamashita, Hirofumi Nakano

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Several fused tri- and tetracyclic quinolines (I and II) with [2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino or [3-(N,N-dimethylamino)propyl]amino side chains were prepared, and their DNA intercalative properties, KB cytotoxicity, antitumor activity (P388 leukemia), and ability to induce topoisomerase II dependent DNA cleavage were investigated. Some compounds having both intercalative ability and KB cytotoxicity were found to be inactive in vivo. However, a positive correlation was seen between the ability to induce topoisomerase II dependent DNA cleavage and antitumor activity in vivo. The indeno- (13a), benzofuro- (21a), and benzothieno- (22a) quinoline derivatives exhibited potent antitumor activities in vitro and in vivo, comparable to those of m-AMSA. They also intercalate DNA and induce topoisomerase II dependent DNA cleavage. Extended screening of 13a showed it to be active against solid tumors such as M5076 sarcoma, B16 melanoma, and colon 38 carcinoma.

Original languageEnglish
Pages (from-to)1295-1300
Number of pages6
JournalJournal of Medicinal Chemistry
Volume32
Issue number6
Publication statusPublished - 1989

Fingerprint

Type II DNA Topoisomerase
DNA Cleavage
Derivatives
DNA
Cytotoxicity
Amsacrine
Quinolines
Leukemia P388
Experimental Melanomas
Sarcoma
Colon
Carcinoma
Tumors
Screening
quinoline
Neoplasms

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Yamato, M., Takeuchi, Y., Hashigaki, K., Ikeda, Y., Ming-rong, C., Takeuchi, K., ... Nakano, H. (1989). Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1. Journal of Medicinal Chemistry, 32(6), 1295-1300.

Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1. / Yamato, Masatoshi; Takeuchi, Yasuo; Hashigaki, Kuniko; Ikeda, Yuji; Ming-rong, Chang; Takeuchi, Kyoko; Matsushima, Mayumi; Tsuruo, Takashi; Tashiro, Tazuko; Tsukagoshi, Shigeru; Yamashita, Yoshinori; Nakano, Hirofumi.

In: Journal of Medicinal Chemistry, Vol. 32, No. 6, 1989, p. 1295-1300.

Research output: Contribution to journalArticle

Yamato, M, Takeuchi, Y, Hashigaki, K, Ikeda, Y, Ming-rong, C, Takeuchi, K, Matsushima, M, Tsuruo, T, Tashiro, T, Tsukagoshi, S, Yamashita, Y & Nakano, H 1989, 'Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1', Journal of Medicinal Chemistry, vol. 32, no. 6, pp. 1295-1300.
Yamato M, Takeuchi Y, Hashigaki K, Ikeda Y, Ming-rong C, Takeuchi K et al. Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1. Journal of Medicinal Chemistry. 1989;32(6):1295-1300.
Yamato, Masatoshi ; Takeuchi, Yasuo ; Hashigaki, Kuniko ; Ikeda, Yuji ; Ming-rong, Chang ; Takeuchi, Kyoko ; Matsushima, Mayumi ; Tsuruo, Takashi ; Tashiro, Tazuko ; Tsukagoshi, Shigeru ; Yamashita, Yoshinori ; Nakano, Hirofumi. / Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1. In: Journal of Medicinal Chemistry. 1989 ; Vol. 32, No. 6. pp. 1295-1300.
@article{dd8c28cf14fc49e48dd8424a7d65e6a6,
title = "Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1",
abstract = "Several fused tri- and tetracyclic quinolines (I and II) with [2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino or [3-(N,N-dimethylamino)propyl]amino side chains were prepared, and their DNA intercalative properties, KB cytotoxicity, antitumor activity (P388 leukemia), and ability to induce topoisomerase II dependent DNA cleavage were investigated. Some compounds having both intercalative ability and KB cytotoxicity were found to be inactive in vivo. However, a positive correlation was seen between the ability to induce topoisomerase II dependent DNA cleavage and antitumor activity in vivo. The indeno- (13a), benzofuro- (21a), and benzothieno- (22a) quinoline derivatives exhibited potent antitumor activities in vitro and in vivo, comparable to those of m-AMSA. They also intercalate DNA and induce topoisomerase II dependent DNA cleavage. Extended screening of 13a showed it to be active against solid tumors such as M5076 sarcoma, B16 melanoma, and colon 38 carcinoma.",
author = "Masatoshi Yamato and Yasuo Takeuchi and Kuniko Hashigaki and Yuji Ikeda and Chang Ming-rong and Kyoko Takeuchi and Mayumi Matsushima and Takashi Tsuruo and Tazuko Tashiro and Shigeru Tsukagoshi and Yoshinori Yamashita and Hirofumi Nakano",
year = "1989",
language = "English",
volume = "32",
pages = "1295--1300",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1

AU - Yamato, Masatoshi

AU - Takeuchi, Yasuo

AU - Hashigaki, Kuniko

AU - Ikeda, Yuji

AU - Ming-rong, Chang

AU - Takeuchi, Kyoko

AU - Matsushima, Mayumi

AU - Tsuruo, Takashi

AU - Tashiro, Tazuko

AU - Tsukagoshi, Shigeru

AU - Yamashita, Yoshinori

AU - Nakano, Hirofumi

PY - 1989

Y1 - 1989

N2 - Several fused tri- and tetracyclic quinolines (I and II) with [2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino or [3-(N,N-dimethylamino)propyl]amino side chains were prepared, and their DNA intercalative properties, KB cytotoxicity, antitumor activity (P388 leukemia), and ability to induce topoisomerase II dependent DNA cleavage were investigated. Some compounds having both intercalative ability and KB cytotoxicity were found to be inactive in vivo. However, a positive correlation was seen between the ability to induce topoisomerase II dependent DNA cleavage and antitumor activity in vivo. The indeno- (13a), benzofuro- (21a), and benzothieno- (22a) quinoline derivatives exhibited potent antitumor activities in vitro and in vivo, comparable to those of m-AMSA. They also intercalate DNA and induce topoisomerase II dependent DNA cleavage. Extended screening of 13a showed it to be active against solid tumors such as M5076 sarcoma, B16 melanoma, and colon 38 carcinoma.

AB - Several fused tri- and tetracyclic quinolines (I and II) with [2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino or [3-(N,N-dimethylamino)propyl]amino side chains were prepared, and their DNA intercalative properties, KB cytotoxicity, antitumor activity (P388 leukemia), and ability to induce topoisomerase II dependent DNA cleavage were investigated. Some compounds having both intercalative ability and KB cytotoxicity were found to be inactive in vivo. However, a positive correlation was seen between the ability to induce topoisomerase II dependent DNA cleavage and antitumor activity in vivo. The indeno- (13a), benzofuro- (21a), and benzothieno- (22a) quinoline derivatives exhibited potent antitumor activities in vitro and in vivo, comparable to those of m-AMSA. They also intercalate DNA and induce topoisomerase II dependent DNA cleavage. Extended screening of 13a showed it to be active against solid tumors such as M5076 sarcoma, B16 melanoma, and colon 38 carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0024361825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024361825&partnerID=8YFLogxK

M3 - Article

C2 - 2542558

AN - SCOPUS:0024361825

VL - 32

SP - 1295

EP - 1300

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -